Fennec Pharmaceuticals Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -57.0% | +289.8% | +615.0% | -19.2% | -38.4% | +122.1% | -28.7% | +20.2% | -0.3% | +67.3% | +55.9% | |
| – | -57.0% | +289.8% | +615.0% | -19.2% | -39.5% | +126.3% | -28.7% | +19.4% | +0.5% | +64.3% | +50.9% | |
| – | -59.2% | +316.8% | +619.8% | -19.4% | -40.1% | +122.3% | -30.5% | +12.7% | -44.2% | +100.7% | +37.9% | |
| – | -59.2% | +316.8% | +619.8% | -19.4% | -40.1% | +122.3% | -30.5% | +12.7% | -44.2% | +100.7% | +37.9% | |
| – | – | – | – | – | – | – | – | – | +470.5% | +46.2% | +79.9% | |
| – | – | – | – | – | – | – | – | – | +274.3% | -50.8% | +47.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -73.2% | -14.6% | +309.0% | -0.4% | +38.7% | +3.3% | +183.0% | +344.3% | +30.4% | +32.0% | -31.1% | |
| – | -73.2% | -14.6% | +309.0% | -0.4% | +38.7% | +3.3% | -29.5% | +178.7% | +63.9% | -8.4% | +51.7% | |
| – | -93.8% | -59.8% | +406.1% | – | – | – | – | – | – | -90.5% | – | |
| – | -3.6% | -17.8% | +250.4% | +20.7% | +56.2% | -2.5% | -50.5% | +207.6% | +58.1% | -14.2% | +42.8% | |
| – | – | – | – | – | – | – | – | +399.2% | +24.2% | -37.5% | – | |
| – | -10.6% | +551.5% | +649.5% | -20.3% | -44.3% | +144.8% | -45.7% | -116.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.7% | +17.9% | +17.6% | +26.7% | +4.6% | +19.1% | +9.7% | +1.0% | +1.1% | +2.7% | +4.7% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.